// App-Quantinova.ai

3355 : Reduced Intensity Vs. Non-Myeloablative Conditioning Regimens for Haploidentical Transplantation in Complete Remission Acute Myeloid Leukemia: A Study from the ALWP of the EBMT

Researchers

Presenter

  • Raynier Devillier

Principal Investigators

  • Jacques-Emmanuel Galimard

  • Myriam Labopin

  • Didier Blaise

  • Emanuele Angelucci

  • Luca Castagna

  • Jiri Pavlu

  • Gerard Socie

  • Massimo Martino

  • Friedrich Stoelzel

  • Gesine Bug

  • Yves Chalandon

  • Benedetto Bruno

  • Victoria Potter

  • Eolia Brissot

  • Bipin N. Savani

  • Arnon Nagler

  • Mohamad Mohty

Medical Centers

  • Institut Paoli-Calmettes, Marseille, France

  • CRCM, INSERM U1068, Marseille, France

  • Aix Marseille University, Medicine Faculty, Marseille, France

  • EBMT-ADWP, Paris, France

  • Hematology and transplant center,IRCCS Ospedale Policlinico San Martino,Genova,Italy

  • Humanitas Cancer Center, IRCCS, Rozzano, Italy

  • Department of Haematology, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, United Kingdom

  • Department of Hematology and Transplantation Unit, APHP Saint Louis Hospital, Paris, France

  • Division of Stem Cell Transplantation and Cellular Therapies, Grande Ospedale Metropolitano BMM, Reggio Calabria, Italy

  • Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany

  • Department of Medicine, Hematology/Oncology, Goethe University of Frankfurt, Frankfurt, Germany

  • Geneva University Hospitals, Geneva, Switzerland

  • S.S.C.V.D Trapianto di Cellule Staminali,A.O.U Citta della Salute e della Scienza di Torino,Presidio Molinette,Torino,Italy

  • Haematological Medicine, Kings College Hospital NHS Foundation Trust, London,

  • Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Sorbonne Université, INSERM UMRs 938, Paris, France, Paris, France

  • Department of Medicine, Division of Hematology-Oncology, Vanderbilt University, Brentwood, TN

  • Director Division of Hematology Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Clinical Hematology, Hospital Saint-Antoine, Paris University UPMC, INSERM U938, Paris, France

Locations

  • France

  • Italy

  • United Kingdom

  • Germany

  • Switzerland

  • United States

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Alemtuzumab

  • Busulfan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved